Search clinical trials for: Valsartan/hydrochlorothiazide

Total 832 results

IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions

Fasting

India
University of Alberta

Completed

Glutamine to Improve Outcomes in Cardiac Surgery (GLADIATOR)

Nosocomial Infection

Canada
West China Hospital

Not yet recruiting

The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction (PERI-STEMI)

STEMI

China
The Cleveland Clinic

Withdrawn

Comparison of ARNI to Alternate Oral Vasodilator Therapies in Patients With Low Cardiac Output (PARAVLO-HF)

Cardiogenic Shock

United States
Novartis

Completed

VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis

Hypertension

Switzerland, Germany
University of Washington
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Repurposing Valsartan May Protect Against Pulmonary Hypertension (REVAMP-PH)

Pulmonary Arterial Hypertension | Right Ventricular Dysfunction | Right Heart Failure | Pulmonary Vascular Disorder

United States
Boehringer Ingelheim
Bayer; GlaxoSmithKline

Completed

Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose

Hypertension

United States, Canada
Novartis

Completed

Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension

Hypertension

Switzerland
HeartDrug Research LLC
Novartis

Unknown

Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics

Diabetes Mellitus

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

Safety and Effect Study of SHR0532 (Drug Code) Tablets in Patients With Mild Hypertension

Hypertension

China
University of New Mexico

Unknown

A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients

Congestive Heart Failure

United States
Boehringer Ingelheim

Completed

3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension

Hypertension

Japan
Universidade do Porto
Rede de Investigação em Saúde (RISE), Laboratório Associado; Faculty of Medicine... and other collaborators

Recruiting

Initiation of ARNi and SGLT2i in Patients With HFrEF (INITIATE)

Heart Failure With Reduced Ejection Fraction

Portugal
Italian Society of Cardiology
Federico II University; University Of Perugia; University of Messina; Azienda Ospedaliero-Universitaria... and other collaborators

Completed

Role of Sacubitril/Valsartan in the Improvement of Heart Failure With Reduced Ejection Fraction

Left Ventricular Dysfunction | Ventricular Remodeling | Heart Failure, Left Sided

Italy
John Paul II Hospital, Krakow

Not yet recruiting

The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection Fraction (CRACOVIA-HF)

Heart Failure With Moderately Reduced Ejection Fraction
Clinical Hospital Heliodor Swiecicki of the Medical...
Medical University of Silesia; Medical University of Gdansk; Medical University... and other collaborators

Recruiting

Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction (PRESENT-HF)

Heart Failure

Poland
Brigham and Women's Hospital

Completed

Replication of the PARADIGM-HF Heart Failure Trial in Healthcare Claims Data.

Heart Failure

United States
Boehringer Ingelheim

Completed

Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy

Hypertension
Boehringer Ingelheim

Completed

Telmisartan Tab Hypertension

Hypertension
Novartis Pharmaceuticals

Terminated

To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy (ARIA)

Non-diabetic Nephropathy

Netherlands
The First Affiliated Hospital of Dalian Medical...
Huazhong University of Science and Technology; LinkDoc Technology (Beijing)...

Recruiting

Huaiqihuang Granule in CKD Stage 3 Primary Glomerulonephritis

Renal Insufficiency, Chronic

China
Novartis Pharmaceuticals

Active, not recruiting

Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC (PARACHUTE-HF)

Heart Failure | Chagas Disease

Brazil, Argentina, Mexico, Colombia
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaborators

Completed

Action to Control Cardiovascular Risk in Diabetes (ACCORD) (ACCORD)

Cardiovascular Diseases | Coronary Disease | Hypertension | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Atherosclerosis | Hypercholesterolemia

United States, Canada
Organon and Co

Completed

Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)

Hypertension
Emmaus Medical, Inc.

Completed

L-glutamine Treatment in Patients With Diverticulosis

Diverticulosis, Colonic

United States
Novartis

Completed

Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus (ViVID)

Hypertension

United States
Radboud University Medical Center

Terminated

Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease

Severe Acute Respiratory Syndrome | COVID-19 | COVID | Acute Respiratory Distress Syndrome | SARS-CoV-2

Netherlands
Novartis

Completed

Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise

Hypertension

Singapore, Hungary, Czech Republic, United Kingdom
VA Office of Research and Development

Completed

Diuretic Comparison Project (DCP)

Hypertension

United States, Puerto Rico
Daiichi Sankyo, Inc.
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension

Essential Hypertension

Belgium, Germany, Netherlands, Slovakia
Boehringer Ingelheim

Completed

A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension

Hypertension

Taiwan
Takeda

Completed

Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.

Hypertension | Obesity

Germany
Teva Pharmaceuticals USA

Completed

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions

Healthy

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

Drug-Drug Interaction Study Between Henagliflozin Proline and Hydrochlorothiazide

Diabetes in Adults

China
Medical University of Silesia
Polpharma Pharmaceutical Company

Terminated

Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients

First Time Dual Chamber Pacemaker Implantation

Poland
Intermountain Health Care, Inc.
Novartis

Terminated

The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial)

Atrial Fibrillation

United States
Organon and Co

Completed

Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)

Hypertension
Emory University

Completed

Effect of Valsartan on Carotid Artery Disease

Atherosclerosis | Carotid Artery Diseases

United States
Novartis Pharmaceuticals

Completed

Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension

Salt-sensitive Hypertension

Taiwan, Singapore, United States, Korea, Republic of, Hong Kong
Novartis

Terminated

Antialbuminuric Effects of Valsartan and Lisinopril

Hypertension | Early Diabetic Nephropathy

Switzerland
Brigham and Women's Hospital
Novartis Pharmaceuticals

Withdrawn

Comparing ARNI With ACE Inhibitor on Endothelial Function (PARADOR)

Heart Failure With Reduced Ejection Fraction
IlDong Pharmaceutical Co Ltd

Completed

A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan (IDCV)

Hypertension
Boehringer Ingelheim

Completed

Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)

Hypertension
University of Cambridge
British Heart Foundation

Unknown

Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension (Pathway 1)

Essential Hypertension | Hypertension, Resistant to Conventional Therapy

United Kingdom
Bayer

Completed

Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life Setting (POTASSIUM)

Primary Hypertension

Poland
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension

Hypertension

Germany, Switzerland, United Kingdom
Farma de Colombia SA

Completed

Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension

Hypertension

Colombia, Ecuador
University of Kansas Medical Center

Recruiting

Improving Pain Management Via Spinal Cord Stimulation and Blood Pressure Reduction (PASSION)

Hypertension | Chronic Pain | Diuretics Drug Reactions | SCS

United States
Oslo University Hospital

Recruiting

Infectious Pseudochromdrosis Caused by Bacillus Cereus (Blue sweat)

Infectious Disease | Bacterial Overgrowth | Pigment Deposition

Norway
Novartis

Completed

Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.

Hypertension

Germany

3

Subscribe